MedPath

Pregnancies following the use of sequential treatment of metformin and incremental doses of letrozole in clomiphen-resistant women with polycystic ovary syndrome

Not Applicable
Conditions
Poly cystic ovarian syndrome.
Polycystic ovarian syndrome
Registration Number
IRCT201109073386N3
Lead Sponsor
Semnan university of medical scienses
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
106
Inclusion Criteria

women who were 19-42 years of age with period of infertility more than 1.5 years; normal serum prolactin and thyroid function tests; having documented patent tubes by hysterosalpingography; no other infertility factor and failed to ovulate with a dose of CC of 150 mg/day for 5 days from day 3 of the period.The women were excluded from the study if they were diabetic; taking any medication that could influence carbohydrate metabolism; had hypertension or abnormal renal or liver function tests; and undergone ovarian drilling.Hirsutism was diagnosed when the Ferriman and Gallway score is >8
The diagnosis of PCOS was according to the Rotterdam Criteria.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ovulation, Pregnancy and Cumulative pregnancy rates in different doses of letrozole. Timepoint: During and the end of treatment. Method of measurement: Sonography and BHCG.
Secondary Outcome Measures
NameTimeMethod
The mean number of follicles= 18 mm, the mean of follicular size and endometrial thickness on the day of HCG administration. Timepoint: During treatment. Method of measurement: Sonograhy and BHCG.
© Copyright 2025. All Rights Reserved by MedPath